Immunome (IMNM)
Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and oth...
- Open
- 24.440
- High
- 24.475
- Low
- 23.550
- Prev. Close
- 24.550
- Volume
- 1.33M
- Turnover
- 31.88M
- Avg Price
- 23.918
- Bid/Ask Ratio
- --
- Amplitude
- 3.77%
- 52wk High
- 30.060
- Volume Ratio
- 1.54
- Turnover Ratio
- 1.23%
Immunome Analyst Rating
View moreForecast & Rating
Sep 11, 2026Price forecast
$36.3151.60%
Forecast & RatingStrong buy
14analysts
- Strong buy78.57%
- Buy21.43%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Quartr · 1 day ago, 03:45 PM
IMNM: Filed NDA for varegacestat and innovative ADC pipeline signal strong oncology momentum
- Market Beat · Aug 19 at 03:00 PM
Immunome (NASDAQ:IMNM) Sets New 12-Month High - Should You Buy?
- Market Beat · Aug 12 at 11:22 PM
Immunome (NASDAQ:IMNM) Director Isaac Barchas Sells 10,125 Shares
